Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
272 hedge funds and large institutions have $942M invested in Avanos Medical in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 76 increasing their positions, 83 reducing their positions, and 34 closing their positions.
1.46% more ownership
Funds ownership: 91.54% → 93% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 83
5% less funds holding
Funds holding: 287 → 272 (-15)
20% less capital invested
Capital invested by funds: $1.18B → $942M (-$243M)
32% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$13.6M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$4.91M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$4.61M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$4.28M |
| 5 |
WHG
Westwood Holdings Group
Dallas,
Texas
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
-$8.44M |
| 2 |
Goldman Sachs
New York
|
-$7.96M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.04M |
| 4 |
BlackRock
New York
|
-$6M |
| 5 |
RC
RGM Capital
Naples,
Florida
|
-$5.25M |
AVNS Hedge Fund Activity: Q3 2022 in Review
272 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2022, worth a combined $942M — down 20% from $1.18B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of AVNS and 23 opened new positions — a net loss of 11 holders — while 83 trimmed existing stakes and 76 added.
The largest buyer was Millennium Management, adding an estimated $13.6M. The largest seller was Balyasny Asset Management, cutting an estimated $8.44M.
- 272 institutional investors held Avanos Medical (AVNS) as of Q3 2022, down from 287 in Q2 2022.
- Funds reported $942M of Avanos Medical stock for Q3 2022, down 20% quarter-over-quarter.
- 23 funds opened new Avanos Medical positions in Q3 2022 and 34 closed out, a net change of -11 holders.
- The largest Avanos Medical buyer in Q3 2022 was Millennium Management, an estimated $13.6M added.
- The largest Avanos Medical seller in Q3 2022 was Balyasny Asset Management, an estimated $8.44M sold.
Based on aggregated 13F filings for Q3 2022.